HBV-IN-33
HBV-IN-33 (C-49), a HBV inhibitor, notably suppresses HBV replication in HepAD38, HepG2-HBV1.3 and HepG2-NTCP cells[1].
Product Specifications
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hbv-in-33.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C(C)N(CC(F)(F)F)C(C)=C1S(=O)(N2CCC[C@@H](C2)C(NC3=CC=C(C(C)=C3)F)=O)=O)OCC
Molecular Formula
C24H29F4N3O5S
Molecular Weight
547.56
References & Citations
[1]Jiaxin Yin, et al. Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice. Eur J Med Chem. 2023 Mar 5;249:115141.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
